$1.35 Billion is the total value of Rock Springs Capital Management LP's 137 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SHPG | New | SHIRE PLCsponsored adr | $22,097,000 | – | 120,042 | +100.0% | 1.64% | – |
| CLSD | New | CLEARSIDE BIOMEDICAL INC | $9,487,000 | – | 1,353,326 | +100.0% | 0.70% | – |
| HOLX | New | HOLOGIC INC | $7,958,000 | – | 230,000 | +100.0% | 0.59% | – |
| ARA | New | AMERICAN RENAL ASSOCIATES HO | $7,243,000 | – | 250,000 | +100.0% | 0.54% | – |
| New | CORSICANTO LTDnote 3.500% 1/1 | $7,214,000 | – | 7,000,000 | +100.0% | 0.53% | – | |
| HRC | New | HILL ROM HLDGS INC | $6,054,000 | – | 120,000 | +100.0% | 0.45% | – |
| New | EGALET CORPnote 5.500% 4/0 | $5,923,000 | – | 7,800,000 | +100.0% | 0.44% | – | |
| INVA | New | INNOVIVA INC | $3,548,000 | – | 336,900 | +100.0% | 0.26% | – |
| TSRO | New | TESARO INCcall | $3,362,000 | – | 40,000 | +100.0% | 0.25% | – |
| MRUS | New | MERUS N V | $2,883,000 | – | 360,811 | +100.0% | 0.21% | – |
| STE | New | STERIS PLC | $2,750,000 | – | 40,000 | +100.0% | 0.20% | – |
| AGLE | New | AEGLEA BIOTHERAPEUTICS INC | $2,547,000 | – | 524,089 | +100.0% | 0.19% | – |
| RLYP | New | RELYPSA INC | $1,388,000 | – | 75,000 | +100.0% | 0.10% | – |
| CERN | New | CERNER CORP | $1,172,000 | – | 20,000 | +100.0% | 0.09% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.4% |
| NEUROCRINE BIOSCIENCES INC | 39 | Q3 2023 | 4.8% |
| PACIRA PHARMACEUTICALS INC | 39 | Q3 2023 | 2.6% |
| ULTRAGENYX PHARMACEUTICAL IN | 39 | Q3 2023 | 1.9% |
| ACADIA HEALTHCARE COMPANY IN | 38 | Q3 2023 | 4.4% |
| ASCENDIS PHARMA A/S | 35 | Q3 2023 | 1.3% |
| INVITAE CORP | 35 | Q3 2023 | 1.8% |
| BIOMARIN PHARMACEUTICAL INC | 35 | Q3 2023 | 1.3% |
| MACROGENICS INC | 35 | Q3 2023 | 0.5% |
| COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.1% |
View Rock Springs Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 3,413,906 | 5.6% |
| Compass Therapeutics, Inc. | February 14, 2023 | 5,333,188 | 4.2% |
| Mirum Pharmaceuticals, Inc. | February 14, 2023 | 1,795,733 | 4.9% |
| PhaseBio Pharmaceuticals IncSold out | February 14, 2023 | 0 | 0.0% |
| Sierra Oncology, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ARDELYX, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| CHIASMA, INCSold out | February 15, 2022 | 0 | 0.0% |
| FIVE PRIME THERAPEUTICS, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| F-star Therapeutics, Inc. | February 15, 2022 | 751,889 | 3.6% |
| Protara Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
View Rock Springs Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-05-01 |
| SC 13G/A | 2024-04-05 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Rock Springs Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.